Sanofi's Dupixent gets U.S. approval to treat eczema in young children
Reuters via Yahoo News· 2 months agoDupixent is now the first approved treatment for moderate-to-severe eczema in young children, Sanofi...
Sanofi's (SNY) Dupixent Gets FDA Nod for Eczema in Infants
Zacks via Yahoo Finance· 2 months agoSanofi (SNY) and partner Regeneron's label expansion application for Dupixent to include infants...
Sanofi (SNY)/Regeneron's Dupixent Meets Eczema Study Goal
Zacks via Yahoo Finance· 11 months agoSanofi (SNY) and Regeneron (REGN)'s Dupixent meet all primary and secondary endpoints in phase III...
Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
Benzinga via Yahoo Finance· 11 months agoThe study met its co-primary and key secondary efficacy endpoints. Investigators randomized 728...
Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now
Investor's Business Daily· 3 months agoDupixent sales beat expectations, while sales of AbbVie's Rinvoq were light at $465 million. Rinvoq...
Eczema drug expected to lift Sanofi earnings amid vaccine worries
Reuters via Yahoo Finance· 2 years agoSanofi is expected to post higher quarterly earnings this week, once more on the back of its star ...
Jeffries Says Sanofi Is 'Most Compelling' European Pharma Stock
GuruFocus.com via Yahoo Finance· 2 years agoDupixent is the first biologic medication approved by the Food and Drug Administration for adults...
Regeneron's (REGN) Dupixent Gets Positive CHMP Opinion for Dermatitis
Zacks via Yahoo Finance· 2 years agoAtopic dermatitis is a chronic inflammatory disease of the...
Sanofi Scores A Big Beat As Dupixent Snags The Spotlight, Again
Investor's Business Daily· 4 months agoDupixent sales rocketed almost 46% in constant currency to nearly $1.7 billion. Sanofi records sales...
Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More
Zacks via Yahoo Finance· 11 months agoREGN and partner Sanofi SNY announced positive results from a study evaluating dermatitis drug ...
Yahoo Web Search
- 110 results
Trending Now
